https://ipfa.nl/ipfa-position-paper/ipfa-position-paper-on-variant-creutzfeldt-jakob-disease-and-plasma-derived-and-urine-derived-medicinal-product/ 2026-10-27T15:35:10+00:00 https://ipfa.nl/ipfa-position-paper/ipfa-position-paper-on-the-zika-virus/ 2026-10-27T15:35:10+00:00 https://ipfa.nl/ipfa-position-paper/ipfa-position-paper-on-hev/ 2026-10-27T15:35:10+00:00 https://ipfa.nl/ipfa-position-paper/ipfa-position-on-acceptance-criteria-for-covid-19-vaccinated-donors/ 2026-10-27T15:35:10+00:00 https://ipfa.nl/ipfa-position-paper/ipfa-position-on-eu-soho-regulation-proposal/ 2026-10-27T15:35:15+00:00 https://ipfa.nl/ipfa-position-paper/burnouf-t-strengers-pfw-risks-of-inhibitors-from-recombinant-factor-viii-a-quarter-of-a-century-to-reach-the-conclusion/ 2026-10-27T15:37:36+00:00 https://ipfa.nl/ipfa-position-paper/strengers-pfw-klein-hg-plasma-is-a-strategic-resource/ 2026-10-27T15:38:53+00:00 https://ipfa.nl/ipfa-position-paper/domanovic-d-tedder-r-blumel-j-zaaijer-h-gallian-p-niederhauser-c-sauleda-oliveras-s-oriordan-j-boland-f-harritshoj-l-nascimento-msj-ciccaglione-ar-politis-c-adlhoch-c-flan-b-ou/ 2026-10-27T15:39:16+00:00 https://ipfa.nl/ipfa-position-paper/qiu-y-vuk-t-bust-l-strengers-p-seidl-chr-self-inspection-and-classification-of-non-compliances/ 2026-10-27T15:39:54+00:00 https://ipfa.nl/ipfa-position-paper/strengers-pfw-evidence-based-clinical-indications-of-plasma-products-and-future-prospects/ 2026-10-27T15:40:27+00:00 https://ipfa.nl/ipfa-position-paper/creutzfeldt-jakob-disease-and-blood-transfusion-safety-c-r-seed-e-a-review-article/ 2026-10-27T15:40:54+00:00 https://ipfa.nl/ipfa-position-paper/the-organization-of-transfusion-and-fractionation-in-france-and-its-regulation-dr-francoise-rossi-review-article/ 2026-10-27T15:41:21+00:00 https://ipfa.nl/ipfa-position-paper/ipfa-donor-information-standard-plasma-derived-medicinal-products-pdmps/ 2026-10-27T15:41:46+00:00